Product Program year 2019 Source: CMS Open Payments

NucyntaER

Drug Opioid Analgesic

NDC 69865-240-02

Open in the dashboard

General payments

$1,049

66 payments

Research payments

$0

0 payments

Through program year 2019, $1,049 in general payments and $0 in research payments were reported against NucyntaER (Opioid Analgesic).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $1,049 66

Breakdown

Who paid General payments · program year 2019
  1. Collegium Pharmaceutical, Inc. $1,049 66 payments
Top recipients General payments · program year 2019
  1. Eric Loudermilk Anesthesiology · Anderson, SC $127 12% · 1 payment
  2. Michael Grier Pain Medicine · Anderson, SC $127 12% · 1 payment
  3. Christopher Fisher Pain Medicine · Las Vegas, NV $57 5% · 5 payments
  4. Ehab Kodsi Physical Medicine & Rehabilitation · Queensbury, NY $48 5% · 3 payments
  5. Philip Doh Pain Medicine · Los Angeles, CA $31 3% · 2 payments

The top 5 of 51 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pain Medicine $238 23% · 6 practitioners
  2. Pain Medicine Anesthesiology $203 19% · 13 practitioners
  3. Anesthesiology $180 17% · 4 practitioners
  4. Physical Medicine & Rehabilitation $160 15% · 10 practitioners
  5. Interventional Pain Medicine Pain Medicine $109 10% · 8 practitioners

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. South Carolina $253 24% · 2 recipients
  2. New York $129 12% · 5 recipients
  3. Colorado $118 11% · 7 recipients
  4. Texas $102 10% · 6 recipients
  5. Florida $77 7% · 5 recipients

The top 5 of 17 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

62,408

Prescriptions dispensed, refills included

Drug cost

$71,961,869

Paid at the pharmacy, in all

Medicare Part D drugs matched to NucyntaER, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Nucynta Tapentadol Hcl Similar name 1,663 34,544 $38,278,749
Nucynta Er Tapentadol Hcl Same name 1,317 27,864 $33,683,120

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 172 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Irving Haber Physical Medicine and Rehabilitation IN 696 $1,052,168 None on record
Nathaniel Brochu Physician Assistant NY 403 $251,322 None on record
Eric Loudermilk Anesthesiology SC 339 $491,327 None on record
Alexander Weingarten Interventional Pain Management NY 306 $337,946 None on record
Kevin Coyle Anesthesiology GA 300 $314,490 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 172 with Patron
66 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record